+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical, Research), Specimen (Bone Marrow, Blood), Product (Kits & Reagents, Blood Collection Tubes), Technology, End Use, and Region with Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • December 2025
  • Region: Global
  • Grand View Research
  • ID: 4764580
REQUEST CUSTOMIZATION
Description Jump to:
The global circulating tumor cells market size was estimated at USD 14.04 billion in 2025 and is projected to reach USD 38.95 billion by 2033, expanding at a CAGR of 13.92% from 2026 to 2033, owing to the non-invasiveness and advantages offered by circulating tumor cells (CTC), it is considered a promising tool in cancer diagnosis. In addition, technological advancements in chip technology are another key factor driving market growth.

Global Circulating Tumor Cells Market Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The report has segmented the global circulating tumor cells market on the basis of technology, application, product, specimen, end use, and region.

Technology Outlook (Revenue, USD Million, 2021-2033)

  • Circulating Tumor Cells CTC Detection & Enrichment Methods
  • CTC Direct Detection Methods
  • CTC Analysis

Application Outlook (Revenue, USD Million, 2021-2033)

  • Clinical
  • Research

Product Outlook (Revenue, USD Million, 2021-2033)

  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems

Specimen Outlook (Revenue, USD Million, 2021-2033)

  • Blood
  • Bone Marrow
  • Other Body Fluids

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Research and Academic Institutes
  • Hospital and Clinics
  • Diagnostic Centers

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Product
1.2.4. Specimen
1.2.5. End use
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Circulating Tumor Cells Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Advancements in chip technology
3.2.1.2. Expanding applications of CTCs
3.2.1.3. Growing demand for early and rapid cancer diagnosis
3.2.1.4. Growing incidence of cancer
3.2.2. Market restraint analysis
3.2.2.1. Consistency-related challenges in CTC detection and enrichment
3.2.2.2. Higher preference for Point-of-Care (POC) testing and nonavailability of POC adaptable CTC tests
3.2.2.3. Lower applicability of CTCs in rare cancers
3.3. Circulating Tumor Cells Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Circulating Tumor Cells Market: Technology Estimates & Trend Analysis
4.1. Technology Segment Dashboard
4.2. Global Circulating Tumor Cells Market Technology Movement Analysis
4.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.4.1. CTC Detection & Enrichment Methods
4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2. Immunocapture (Label-based)
4.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.2. Positive Selection
4.4.1.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.2.3. Negative Selection
4.4.1.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3. Size-based Separation (Label-free)
4.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3.2. Membrane-based
4.4.1.3.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.3.3. Microfluidic-based
4.4.1.3.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.4. Density-based Separation (Label-free)
4.4.1.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.1.5. Combined Methods
4.4.1.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. CTC Direct Detection Methods
4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.2. SERS
4.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.3. Microscopy
4.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2.4. Others
4.4.2.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. CTC Analysis
4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Circulating Tumor Cells Market: Application Estimates & Trend Analysis
5.1. Application Segment Dashboard
5.2. Global Circulating Tumor Cells Market Application Movement Analysis
5.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.4.1. Clinical
5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.2. Risk Assessment
5.4.1.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.1.3. Screening and Monitoring
5.4.1.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Research
5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2. Cancer Stem Cell & Tumorogenesis Research
5.4.2.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.3. Drug/Therapy Development
5.4.2.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Circulating Tumor Cells Market: Product Estimates & Trend Analysis
6.1. Product Segment Dashboard
6.2. Global Circulating Tumor Cells Market Product Movement Analysis
6.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.4.1. Kits & reagents
6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Blood collection tubes
6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Devices or systems
6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Circulating Tumor Cells Market: Specimen Estimates & Trend Analysis
7.1. Specimen Segment Dashboard
7.2. Global Circulating Tumor Cells Market Specimen Movement Analysis
7.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by Specimen, 2021 to 2033 (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
7.4.1. Blood
7.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. Bone marrow
7.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Other body fluids
7.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Circulating Tumor Cells Market: End Use Estimates & Trend Analysis
8.1. End Use Segment Dashboard
8.2. Global Circulating Tumor Cells Market End Use Movement Analysis
8.3. Global Circulating Tumor Cells Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
8.4.1. Research and academic institutes
8.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. Hospital and clinics
8.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Diagnostic centers
8.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Circulating Tumor Cells Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2025 & 2033
9.2. Regional Market Dashboard
9.3. North America
9.3.1. U.S.
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework
9.3.1.3. Competitive scenario
9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
9.3.1.5. Target disease prevalence
9.3.2. Canada
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework
9.3.2.3. Competitive scenario
9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
9.3.2.5. Target disease prevalence
9.3.3. Mexico
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework
9.3.3.3. Competitive scenario
9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
9.3.3.5. Target disease prevalence
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Competitive scenario
9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
9.4.1.5. Target disease prevalence
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2.5. Target disease prevalence
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3.5. Target disease prevalence
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4.5. Target disease prevalence
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework
9.4.5.3. Competitive scenario
9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
9.4.5.5. Target disease prevalence
9.4.6. Norway
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework
9.4.6.3. Competitive scenario
9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
9.4.6.5. Target disease prevalence
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Regulatory framework
9.4.7.3. Competitive scenario
9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
9.4.7.5. Target disease prevalence
9.4.8. Denmark
9.4.8.1. Key country dynamics
9.4.8.2. Regulatory framework
9.4.8.3. Competitive scenario
9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
9.4.8.5. Target disease prevalence
9.5. Asia-Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
9.5.1.5. Target disease prevalence
9.5.2. China
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
9.5.2.5. Target disease prevalence
9.5.3. India
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
9.5.3.5. Target disease prevalence
9.5.4. Australia
9.5.4.1. Key country dynamics
9.5.4.2. Regulatory framework
9.5.4.3. Competitive scenario
9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
9.5.4.5. Target disease prevalence
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Regulatory framework
9.5.5.3. Competitive scenario
9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
9.5.5.5. Target disease prevalence
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Regulatory framework
9.5.6.3. Competitive scenario
9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
9.5.6.5. Target disease prevalence
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework
9.6.1.3. Competitive scenario
9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
9.6.1.5. Target disease prevalence
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
9.6.2.5. Target disease prevalence
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework
9.7.1.3. Competitive scenario
9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
9.7.1.5. Target disease prevalence
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework
9.7.2.3. Competitive scenario
9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.7.2.5. Target disease prevalence
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework
9.7.3.3. Competitive scenario
9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.7.3.5. Target disease prevalence
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework
9.7.4.3. Competitive scenario
9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
9.7.4.5. Target disease prevalence
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, by Key Market Participants
10.2. Company/Competition Categorization
10.3. Key company position analysis, 2025
10.4. Key Company Profiles
10.4.1. QIAGEN
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Bio-Techne Corp.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Precision Medicine Group, LLC.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Bio-Rad Laboratories, Inc.
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Natera, Inc.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Illumina, Inc.
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Cell Microsystems
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Greiner Bio One International GmbH
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Ikonisys Inc.
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Miltenyi Biotec
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America circulating tumor cells market, by region, 2021-2033 (USD Million)
Table 3 North America circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 4 North America circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 5 North America circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 6 North America circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 7 North America circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 8 U.S. circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 9 U.S. circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 10 U.S. circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 11 U.S. circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 12 U.S. circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 13 Canada circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 14 Canada circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 15 Canada circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 16 Canada circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 17 Canada circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 18 Mexico circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 19 Mexico circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 20 Mexico circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 21 Mexico circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 22 Mexico circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 23 Europe circulating tumor cells market, by region, 2021-2033 (USD Million)
Table 24 Europe circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 25 Europe circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 26 Europe circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 27 Europe circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 28 Europe circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 29 UK circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 30 UK circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 31 UK circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 32 UK circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 33 UK circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 34 Germany circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 35 Germany circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 36 Germany circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 37 Germany circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 38 Germany circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 39 Italy circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 40 Italy circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 41 Italy circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 42 Italy circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 43 Italy circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 44 France circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 45 France circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 46 France circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 47 France circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 48 France circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 49 Spain circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 50 Spain circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 51 Spain circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 52 Spain circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 53 Spain circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 54 Sweden circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 55 Sweden circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 56 Sweden circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 57 Sweden circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 58 Sweden circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 59 Denmark circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 60 Denmark circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 61 Denmark circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 62 Denmark circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 63 Denmark circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 64 Norway circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 65 Norway circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 66 Norway circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 67 Norway circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 68 Norway circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 69 Asia-Pacific circulating tumor cells market, by region, 2021-2033 (USD Million)
Table 70 Asia-Pacific circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 71 Asia-Pacific circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 72 Asia-Pacific circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 73 Asia-Pacific circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 74 Asia-Pacific circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 75 China circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 76 China circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 77 China circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 78 China circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 79 China circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 80 Japan circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 81 Japan circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 82 Japan circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 83 Japan circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 84 Japan circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 85 India circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 86 India circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 87 India circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 88 India circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 89 India circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 90 South Korea circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 91 South Korea circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 92 South Korea circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 93 South Korea circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 94 South Korea circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 95 Australia circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 96 Australia circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 97 Australia circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 98 Australia circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 99 Australia circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 100 Thailand circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 101 Thailand circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 102 Thailand circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 103 Thailand circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 104 Thailand circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 105 Latin America circulating tumor cells market, by region, 2021-2033 (USD Million)
Table 106 Latin America circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 107 Latin America circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 108 Latin America circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 109 Latin America circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 110 Latin America circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 111 Brazil circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 112 Brazil circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 113 Brazill circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 114 Brazil circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 115 Brazil circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 116 Argentina circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 117 Argentina circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 118 Argentina circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 119 Argentina circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 120 Argentina circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 121 Middle East Africa circulating tumor cells market, by region, 2021-2033 (USD Million)
Table 122 Middle East Africa circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 123 Middle East Africa circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 124 Middle East Africa circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 125 Middle East Africa circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 126 Middle East Africa circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 127 South Africa circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 128 South Africa circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 129 South Africa circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 130 South Africa circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 131 South Africa circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 132 Saudi Arabia circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 133 Saudi Arabia circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 134 Saudi Arabia circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 135 Saudi Arabia circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 136 Saudi Arabia circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 137 UAE circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 138 UAE circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 139 UAE circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 140 UAE circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 141 UAE circulating tumor cells market, by end use, 2021-2033 (USD Million)
Table 142 Kuwait circulating tumor cells market, by technology, 2021-2033 (USD Million)
Table 143 Kuwait circulating tumor cells market, by application, 2021-2033 (USD Million)
Table 144 Kuwait circulating tumor cells market, by product, 2021-2033 (USD Million)
Table 145 Kuwait circulating tumor cells market, by specimen, 2021-2033 (USD Million)
Table 146 Kuwait circulating tumor cells market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Circulating tumor cells market: market outlook
Figure 9 Circulating tumor cells competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Circulating tumor cells market driver impact
Figure 15 Circulating tumor cells market restraint impact
Figure 16 Circulating tumor cells market strategic initiatives analysis
Figure 17 Circulating tumor cells market: Technology movement analysis
Figure 18 Circulating tumor cells market: Technology outlook and key takeaways
Figure 19 CTC detection & enrichment methods market estimates and forecast, 2021-2033
Figure 20 Immunocapture (label-based) estimates and forecast, 2021-2033
Figure 21 Positive selection market estimates and forecast, 2021-2033
Figure 22 Negative selection estimates and forecast, 2021-2033
Figure 23 Size-based separation (label-free) market estimates and forecast, 2021-2033
Figure 24 Membrane-based estimates and forecast, 2021-2033
Figure 25 Microfluidic-based estimates and forecast, 2021-2033
Figure 26 Density-based Separation (Label-free) estimates and forecast, 2021-2033
Figure 27 Combined Methods estimates and forecast, 2021-2033
Figure 28 CTC direct detection methods estimate and forecast, 2021-2033
Figure 29 SERS estimates and forecast, 2021-2033
Figure 30 Microscopy estimates and forecast, 2021-2033
Figure 31 Others estimates and forecast, 2021-2033
Figure 32 CTC Analysis estimates and forecast, 2021-2033
Figure 33 Circulating tumor cells Market: Application movement Analysis
Figure 34 Circulating tumor cells market: Application outlook and key takeaways
Figure 35 Clinical/ Liquid Biopsy market estimates and forecasts, 2021-2033
Figure 36 Risk Assessment market estimates and forecasts, 2021-2033
Figure 37 Screening and Monitoring market estimates and forecasts, 2021-2033
Figure 38 Research market estimates and forecasts, 2021-2033
Figure 39 Cancer Stem Cell & Tumorogenesis Research market estimates and forecasts, 2021-2033
Figure 40 Drug/Therapy Development market estimates and forecasts, 2021-2033
Figure 41 Circulating tumor cells Market: Product movement Analysis
Figure 42 Circulating tumor cells market: Product outlook and key takeaways
Figure 43 Kits & reagents market estimates and forecasts, 2021-2033
Figure 44 Blood collection tubes market estimates and forecasts, 2021-2033
Figure 45 Devices or Systems market estimates and forecasts, 2021-2033
Figure 46 Circulating tumor cells Market: Specimen movement Analysis
Figure 47 Circulating tumor cells market: Specimen outlook and key takeaways
Figure 48 Blood market estimates and forecasts, 2021-2033
Figure 49 Bone marrow market estimates and forecasts, 2021-2033
Figure 50 Other body fluids market estimates and forecasts, 2021-2033
Figure 51 Circulating tumor cells Market: End use movement Analysis
Figure 52 Circulating tumor cells market: End use outlook and key takeaways
Figure 53 Research and academic institutes market estimates and forecasts, 2021-2033
Figure 54 Hospital and clinics market estimates and forecasts, 2021-2033
Figure 55 Diagnostic centers market estimates and forecasts, 2021-2033
Figure 56 Global circulating tumor cells market: Regional movement analysis
Figure 57 Global circulating tumor cells market: Regional outlook and key takeaways
Figure 58 North America, by country
Figure 59 North America
Figure 60 North America market estimates and forecasts, 2021-2033
Figure 61 U.S. country dynamics
Figure 62 U.S. market estimates and forecasts, 2021-2033
Figure 63 Canada country dynamics
Figure 64 Canada market estimates and forecasts, 2021-2033
Figure 65 Mexico country dynamics
Figure 66 Mexico market estimates and forecasts, 2021-2033
Figure 67 Europe market estimates and forecasts, 2021-2033
Figure 68 UK country dynamics
Figure 69 UK market estimates and forecasts, 2021-2033
Figure 70 Germany country dynamics
Figure 71 Germany market estimates and forecasts, 2021-2033
Figure 72 France country dynamics
Figure 73 France market estimates and forecasts, 2021-2033
Figure 74 Italy country dynamics
Figure 75 Italy market estimates and forecasts, 2021-2033
Figure 76 Spain country dynamics
Figure 77 Spain market estimates and forecasts, 2021-2033
Figure 78 Denmark country dynamics
Figure 79 Denmark market estimates and forecasts, 2021-2033
Figure 80 Sweden country dynamics
Figure 81 Sweden market estimates and forecasts, 2021-2033
Figure 82 Norway country dynamics
Figure 83 Norway market estimates and forecasts, 2021-2033
Figure 84 Asia-Pacific market estimates and forecasts, 2021-2033
Figure 85 China country dynamics
Figure 86 China market estimates and forecasts, 2021-2033
Figure 87 Japan country dynamics
Figure 88 Japan market estimates and forecasts, 2021-2033
Figure 89 India country dynamics
Figure 90 India market estimates and forecasts, 2021-2033
Figure 91 Thailand country dynamics
Figure 92 Thailand market estimates and forecasts, 2021-2033
Figure 93 South Korea country dynamics
Figure 94 South Korea market estimates and forecasts, 2021-2033
Figure 95 Australia country dynamics
Figure 96 Australia market estimates and forecasts, 2021-2033
Figure 97 Latin America market estimates and forecasts, 2021-2033
Figure 98 Brazil country dynamics
Figure 99 Brazil market estimates and forecasts, 2021-2033
Figure 100 Argentina country dynamics
Figure 101 Argentina market estimates and forecasts, 2021-2033
Figure 102 Middle East and Africa market estimates and forecasts, 2021-2033
Figure 103 South Africa country dynamics
Figure 104 South Africa market estimates and forecasts, 2021-2033
Figure 105 Saudi Arabia country dynamics
Figure 106 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 107 UAE country dynamics
Figure 108 UAE market estimates and forecasts, 2021-2033
Figure 109 Kuwait country dynamics
Figure 110 Kuwait market estimates and forecasts, 2021-2033

Companies Mentioned

The companies profiled in this Circulating Tumor Cells market report include:
  • QIAGEN
  • Bio-Techne Corporation
  • Precision Medicine Group, LLC.
  • Bio-Rad Laboratories, Inc.
  • Natera, Inc.
  • Illumina, Inc.
  • Cell Microsystems
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • Miltenyi Biotec

Table Information

Report AttributeDetails
No. of Pages120
PublishedDecember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 14.04 Billion
Forecasted Market Value ( USD ) by 2033 $ 38.95 Billion
Compound Annual Growth Rate13.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Circulating Tumor CellDetection Market - Global Forecast 2026-2032 - Product Image

Circulating Tumor CellDetection Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Liquid Biopsy For Early Cancer Detection And Monitoring Market Size, Share & Trends Analysis Report By Biomarker (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)), By Technology, By Cancer, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Liquid Biopsy For Early Cancer Detection And Monitoring Market Size, Share & Trends Analysis Report By Biomarker (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)), By Technology, By Cancer, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 136 Pages
  • Global
From
Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033 - Product Image

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Circulating Tumor Cells Market Report 2025 - Product Image

Circulating Tumor Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.